MRD / Regn No. : 20260000422 Date : 01/07/2026
Patient Name : Selvi Ramesh Age & Gender : 51 Yrs. / Female
Contact No. : 9445467149 UHID :
Ht / Wt / BMI : 150 / 76.8 / 34.13 BP S / BP D : 137 / 91
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (19/May/2025) | OBESITY (19/May/2022) | MILD TSH ELEVATION (19/May/2026) | NODULAR THYROID DISEASE (19/May/2026) | A2G1 DKD (19/May/2026) | DYSLIPIDEMIA (19/May/2026) | VITAMIN D DEFICIENCY (19/May/2026) |
Subjective : TAH BSO 1 YEAR,NEW ONSET DM
Objective : L THYROMEGALY
Analysis : TYPE 2 DM,NODULAR THYROID DISEASE,SUBCENTIMETRIC NODULES,MILD TSH ELEVATION,VITAMIN D DEFICEINCY,A2G1 DKD
Plan : INCREASE SEMAGLUTIDE TO 0.5 MG,ADD ARB,SEE ME IN 1 MONTH  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 95 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 141 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION 		PO 1-0-0 BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
2 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL 		PO 0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
3 CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D 		PO 0-0-1 AT BEDTIME
 TILL NEXT VISIT
4 ROSUVASTATIN 10 MG
ROSUVAS 10 MG 		0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
5 INJECTION SEMAGLUTIDE 0.5 MG
SEMATRINITY 0.5
Medicine For DIABETES OBESITY 		SQ ONCE A WEEK SUBCUTANEOUS
 TILL VISIT DATE MENTIONED
MAY CAUSE VOMITING AND VISUAL DISTURBANCE
6 TELMISARTAN 40 MG
ERITEL 40 MG 		0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE HIGH POTASSIUM
       
Refill : 0 / Substitution:    
Education :
Next Visit : 31/Jul/2026
Tests Suggested For Next Visit : FBS 2HPP
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: